We are live on ! Find out more
GBT

Global Blood Therapeutics, Inc.
GBT

Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

2 hedge funds and large institutions have $42.1K invested in Global Blood Therapeutics, Inc. in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 239 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 247 → 2 (-245)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $4.73B → $42.1K (-$4.73B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 239

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-245
Holders Change %
-99.19%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
239
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$428M
2
BlackRock
BlackRock
New York
-$323M
3
BBA
Baker Bros. Advisors
New York
-$254M
4
PCM
Pentwater Capital Management
Florida
-$218M
5
State Street
State Street
Massachusetts
-$162M
Name Holding Trade Value Shares
Change 		Change in
Stake
YCM
101
Yakira Capital Management
Connecticut
– -$6.04M -88,771 Closed
Dimensional Fund Advisors
102
Dimensional Fund Advisors
Texas
– -$6.01M -88,277 Closed
Canada Pension Plan Investment Board
103
Canada Pension Plan Investment Board
Ontario, Canada
– -$6M -88,100 Closed
CL
104
CSS LLC
Illinois
– -$5.74M -84,219 Closed
Verition Fund Management
105
Verition Fund Management
Connecticut
– -$5.45M -80,094 Closed
MS
106
Maven Securities
Jersey
– -$5.45M -80,000 Closed
California State Teachers Retirement System (CalSTRS)
107
California State Teachers Retirement System (CalSTRS)
California
– -$5.36M -78,720 Closed
AIMCA
108
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$5.11M -75,100 Closed
WMSA
109
Weiss Multi-Strategy Advisers
New York
– -$4.5M -66,052 Closed
Jane Street
110
Jane Street
New York
– -$4.35M -63,922 Closed
JF
111
Jump Financial
Illinois
– -$4.26M -62,589 Closed
VI
112
Vestcor Inc
New Brunswick, Canada
– -$4.24M -62,286 Closed
Hudson Bay Capital Management
113
Hudson Bay Capital Management
Connecticut
– -$4.09M -60,000 Closed
Ohio Public Employees Retirement System (OPERS)
114
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$4.09M -60,000 Closed
EAM
115
Erste Asset Management
Austria
– -$3.95M -58,000 Closed
Legal & General Group
116
Legal & General Group
United Kingdom
– -$3.86M -56,676 Closed
Citadel Advisors
117
Citadel Advisors
Florida
– -$3.5M -51,397 Closed
DAM
118
DLD Asset Management
New York
– -$3.4M -50,000 Closed
Susquehanna International Group
119
Susquehanna International Group
Pennsylvania
– -$3.24M -47,540 Closed
New York State Common Retirement Fund
120
New York State Common Retirement Fund
New York
– -$3.17M -46,558 Closed
GI
121
GAMCO Investors
Connecticut
– -$3.17M -46,544 Closed
HA
122
Havens Advisors
New York
– -$3.13M -46,000 Closed
Invesco
123
Invesco
Georgia
– -$3.06M -44,967 Closed
Walleye Capital
124
Walleye Capital
New York
– -$3M -44,084 Closed
BFM
125
Boothbay Fund Management
New York
– -$2.97M -43,670 Closed
3 4
5
6 7

GBT Hedge Fund Activity: Q4 2022 in Review

2 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Global Blood Therapeutics, Inc. (GBT) for Q4 2022, worth a combined $42.1K — down 100% from $4.73B a quarter earlier.

Sellers outnumbered buyers: 239 funds closed out of GBT and 0 opened new positions — a net loss of 239 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $428M sold.

  • 2 institutional investors held Global Blood Therapeutics, Inc. (GBT) as of Q4 2022, down from 247 in Q3 2022.
  • Funds reported $42.1K of Global Blood Therapeutics, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Global Blood Therapeutics, Inc. positions in Q4 2022 and 239 closed out, a net change of -239 holders.
  • The largest Global Blood Therapeutics, Inc. seller in Q4 2022 was Vanguard Group, an estimated $428M sold.

Based on aggregated 13F filings for Q4 2022.